Hemostasis in acquired hemophilia - Role of intracavitary instillation of EACA

S. Sahu, R. Raipancholia, F. K. Pardiwalla, A. V. Pathare

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

An 82 year old man developed antibodies against coagulation factor VIII: C without any apparent cause. Bleeding from the soft tissue cavity could not be controlled by factor VIII:C concentrates, immunosuppression with steroids and intravenous immunoglobulin therapy in the standard dosages. However, a single injection nf Epsilon Aminocaproic Acid (EACA) instilled into the cavity under aseptic precautions achieved lasting hemostasis with resultant wound healing.

Original languageEnglish
Pages (from-to)88-90
Number of pages3
JournalJournal of Postgraduate Medicine
Volume42
Issue number3
Publication statusPublished - 1996

Fingerprint

Aminocaproic Acid
Factor VIII
Hemophilia A
Hemostasis
Passive Immunization
Intravenous Immunoglobulins
Wound Healing
Immunosuppression
Steroids
Hemorrhage
Injections
Antibodies

Keywords

  • EACA
  • Factor VIII C
  • Hemophilia
  • Hemostasis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hemostasis in acquired hemophilia - Role of intracavitary instillation of EACA. / Sahu, S.; Raipancholia, R.; Pardiwalla, F. K.; Pathare, A. V.

In: Journal of Postgraduate Medicine, Vol. 42, No. 3, 1996, p. 88-90.

Research output: Contribution to journalArticle

Sahu, S. ; Raipancholia, R. ; Pardiwalla, F. K. ; Pathare, A. V. / Hemostasis in acquired hemophilia - Role of intracavitary instillation of EACA. In: Journal of Postgraduate Medicine. 1996 ; Vol. 42, No. 3. pp. 88-90.
@article{43c2e0a48b54464e84a30973b9265bb1,
title = "Hemostasis in acquired hemophilia - Role of intracavitary instillation of EACA",
abstract = "An 82 year old man developed antibodies against coagulation factor VIII: C without any apparent cause. Bleeding from the soft tissue cavity could not be controlled by factor VIII:C concentrates, immunosuppression with steroids and intravenous immunoglobulin therapy in the standard dosages. However, a single injection nf Epsilon Aminocaproic Acid (EACA) instilled into the cavity under aseptic precautions achieved lasting hemostasis with resultant wound healing.",
keywords = "EACA, Factor VIII C, Hemophilia, Hemostasis",
author = "S. Sahu and R. Raipancholia and Pardiwalla, {F. K.} and Pathare, {A. V.}",
year = "1996",
language = "English",
volume = "42",
pages = "88--90",
journal = "Journal of Postgraduate Medicine",
issn = "0022-3859",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "3",

}

TY - JOUR

T1 - Hemostasis in acquired hemophilia - Role of intracavitary instillation of EACA

AU - Sahu, S.

AU - Raipancholia, R.

AU - Pardiwalla, F. K.

AU - Pathare, A. V.

PY - 1996

Y1 - 1996

N2 - An 82 year old man developed antibodies against coagulation factor VIII: C without any apparent cause. Bleeding from the soft tissue cavity could not be controlled by factor VIII:C concentrates, immunosuppression with steroids and intravenous immunoglobulin therapy in the standard dosages. However, a single injection nf Epsilon Aminocaproic Acid (EACA) instilled into the cavity under aseptic precautions achieved lasting hemostasis with resultant wound healing.

AB - An 82 year old man developed antibodies against coagulation factor VIII: C without any apparent cause. Bleeding from the soft tissue cavity could not be controlled by factor VIII:C concentrates, immunosuppression with steroids and intravenous immunoglobulin therapy in the standard dosages. However, a single injection nf Epsilon Aminocaproic Acid (EACA) instilled into the cavity under aseptic precautions achieved lasting hemostasis with resultant wound healing.

KW - EACA

KW - Factor VIII C

KW - Hemophilia

KW - Hemostasis

UR - http://www.scopus.com/inward/record.url?scp=0030177447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030177447&partnerID=8YFLogxK

M3 - Article

VL - 42

SP - 88

EP - 90

JO - Journal of Postgraduate Medicine

JF - Journal of Postgraduate Medicine

SN - 0022-3859

IS - 3

ER -